Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
Accolade (Nasdaq: ACCD) has announced a strategic partnership with Oshi Health, a virtual GI clinic, expanding its digestive health solutions alongside existing partner Cylinder. The collaboration aims to address the significant healthcare challenge of GI diseases, which affect 70 million Americans annually and generate $136 billion in healthcare costs.
The partnership tackles critical issues in GI care, including lengthy diagnosis waiting times (2-3 years on average) and access to comprehensive treatment. Oshi Health provides integrated care through virtual consultations with GI specialists, dietitians, and psychologists, achieving 92% symptom control rate within 10 weeks.
This initiative specifically targets digestive health conditions, which represent the second leading cause of workplace absences. Oshi Health's services are in-network with major insurance plans, and the partnership includes purpose-built integrations to improve access to specialized GI care for Accolade's customer base.
Accolade (Nasdaq: ACCD) ha annunciato una partnership strategica con Oshi Health, una clinica virtuale specializzata in gastroenterologia, ampliando le sue soluzioni per la salute digestiva insieme al partner esistente Cylinder. La collaborazione mira a affrontare la significativa sfida sanitaria delle malattie gastrointestinali, che colpiscono 70 milioni di americani ogni anno e generano 136 miliardi di dollari in costi sanitari.
La partnership affronta questioni critiche nella cura gastrointestinale, inclusi i lunghi tempi di attesa per la diagnosi (2-3 anni in media) e l'accesso a trattamenti completi. Oshi Health offre cure integrate attraverso consultazioni virtuali con specialisti GI, dietisti e psicologi, raggiungendo un tasso di controllo dei sintomi del 92% entro 10 settimane.
Questa iniziativa si concentra specificamente sulle condizioni di salute digestiva, che rappresentano la seconda causa principale di assenze dal lavoro. I servizi di Oshi Health sono inclusi nella rete di importanti piani assicurativi, e la partnership prevede integrazioni progettate appositamente per migliorare l'accesso alle cure specialistiche GI per la clientela di Accolade.
Accolade (Nasdaq: ACCD) ha anunciado una asociación estratégica con Oshi Health, una clínica virtual de gastroenterología, ampliando sus soluciones de salud digestiva junto con el socio existente Cylinder. La colaboración tiene como objetivo abordar el importante desafío de salud que representan las enfermedades gastrointestinales, que afectan a 70 millones de estadounidenses anualmente y generan 136 mil millones de dólares en costos de atención médica.
La asociación aborda problemas críticos en la atención gastrointestinal, incluidos los largos tiempos de espera para el diagnóstico (2-3 años de promedio) y el acceso a tratamientos integrales. Oshi Health proporciona atención integrada a través de consultas virtuales con especialistas en GI, dietistas y psicólogos, logrando una tasa de control de síntomas del 92% en 10 semanas.
Esta iniciativa se dirige específicamente a las condiciones de salud digestiva, que representan la segunda causa principal de ausencias laborales. Los servicios de Oshi Health están dentro de la red de los principales planes de seguros, y la asociación incluye integraciones diseñadas para mejorar el acceso a la atención especializada en GI para la base de clientes de Accolade.
Accolade (Nasdaq: ACCD)는 가상 위장 클리닉인 Oshi Health와 전략적 파트너십을 발표하며, 기존 파트너인 Cylinder와 함께 소화 건강 솔루션을 확장합니다. 이번 협력은 매년 7천만 명의 미국인이 영향을 받는 위장 질환이라는 중요한 의료 문제를 해결하는 것을 목표로 하며, 이로 인해 1,360억 달러의 의료 비용이 발생합니다.
이 파트너십은 진단 대기 시간(평균 2-3년)과 포괄적인 치료 접근 등 위장 치료의 주요 문제를 다룹니다. Oshi Health는 GI 전문가, 영양사 및 심리학자와의 가상 상담을 통해 통합 치료를 제공하며, 10주 이내에 92%의 증상 조절률을 달성합니다.
이 이니셔티브는 근무 결근의 두 번째 주요 원인인 소화 건강 상태를 특별히 겨냥하고 있습니다. Oshi Health의 서비스는 주요 보험 플랜 내에 있으며, 이 파트너십은 Accolade의 고객 기반을 위한 전문 GI 치료 접근을 개선하기 위해 특별히 설계된 통합을 포함합니다.
Accolade (Nasdaq: ACCD) a annoncé un partenariat stratégique avec Oshi Health, une clinique virtuelle spécialisée en gastro-entérologie, élargissant ses solutions de santé digestive aux côtés de son partenaire existant Cylinder. La collaboration vise à relever le défi sanitaire majeur des maladies gastro-intestinales, qui touchent 70 millions d'Américains chaque année et génèrent 136 milliards de dollars de coûts de santé.
Le partenariat s'attaque à des questions critiques dans les soins gastro-intestinaux, notamment les longs délais d'attente pour le diagnostic (2-3 ans en moyenne) et l'accès à des traitements complets. Oshi Health propose des soins intégrés grâce à des consultations virtuelles avec des spécialistes GI, des diététiciens et des psychologues, atteignant un taux de contrôle des symptômes de 92 % en 10 semaines.
Cette initiative cible spécifiquement les conditions de santé digestive, qui représentent la deuxième cause principale d'absences au travail. Les services d'Oshi Health sont dans le réseau des principaux plans d'assurance, et le partenariat comprend des intégrations spécialement conçues pour améliorer l'accès aux soins spécialisés en GI pour la clientèle d'Accolade.
Accolade (Nasdaq: ACCD) hat eine strategische Partnerschaft mit Oshi Health, einer virtuellen GI-Klinik, angekündigt, um seine Lösungen für die Verdauungsgesundheit zusammen mit dem bestehenden Partner Cylinder auszubauen. Die Zusammenarbeit zielt darauf ab, die erhebliche Herausforderung im Gesundheitswesen durch GI-Erkrankungen anzugehen, die jährlich 70 Millionen Amerikaner betreffen und 136 Milliarden Dollar an Gesundheitskosten verursachen.
Die Partnerschaft beschäftigt sich mit kritischen Fragen der GI-Versorgung, einschließlich langer Wartezeiten für Diagnosen (im Durchschnitt 2-3 Jahre) und dem Zugang zu umfassenden Behandlungen. Oshi Health bietet integrierte Pflege durch virtuelle Konsultationen mit GI-Spezialisten, Ernährungsberatern und Psychologen und erreicht eine Symptomkontrollrate von 92 % innerhalb von 10 Wochen.
Diese Initiative zielt speziell auf Verdauungsgesundheitszustände ab, die die zweithäufigste Ursache für Fehlzeiten am Arbeitsplatz darstellen. Die Dienstleistungen von Oshi Health sind in den wichtigsten Versicherungsplänen enthalten, und die Partnerschaft umfasst speziell entwickelte Integrationen, um den Zugang zu spezialisierten GI-Behandlungen für die Kundenbasis von Accolade zu verbessern.
- Partnership expands access to specialized GI care services
- Oshi Health reports 92% success rate in symptom control
- In-network coverage with major insurance plans
- Addresses $136B market opportunity in GI healthcare
- None.
Insights
Accolade's new partnership with Oshi Health represents a strategic expansion of its healthcare ecosystem, specifically targeting the substantial digestive health market that affects 70 million Americans and drives
The partnership addresses a significant pain point in healthcare delivery - GI conditions are the second leading cause of missed work and the leading cause of avoidable ER visits, representing a clear opportunity to reduce employer healthcare costs through better condition management. Oshi's reported
From a business perspective, this partnership enhances Accolade's value proposition in the competitive employer benefits space by addressing a common condition with substantial workplace impact. The integration of Oshi's specialized virtual care model into Accolade's platform potentially creates a more compelling offering for both existing and prospective clients. However, the announcement lacks specific financial projections or exclusivity terms, making the immediate revenue impact difficult to quantify. This appears to be part of Accolade's broader strategy to build a comprehensive healthcare navigation and specialty care coordination platform rather than a transformative single partnership.
Partnership increases access to specialized, whole-person clinical care for people managing digestive health conditions
GI diseases are a common and costly health issue in
Oshi provides an integrated team of GI specialists – including advanced practice providers, registered dietitians, and licensed psychologists with expertise in gut-brain health – who work together to accelerate the time to diagnosis and to achieve sustainable symptom control. Oshi offers immediate access to high-touch care through telehealth, continuous patient support, and specialized dietary and behavioral health interventions that are proven effective yet hard to find. Oshi's care team can diagnose, prescribe and treat, iterate with patients to identify and address the root causes of symptoms, and coordinate care with patients' primary care physicians. On average,
"Oshi Health embraces whole-person care for individuals with digestive health challenges," said Dr. Connie Hwang, Accolade's Chief Clinical Officer. "Their focus on personalized treatment plans and timely access to experienced, multidisciplinary GI clinicians aligns with Accolade's commitment to high-quality care. Together, we are empowering employees with specialized expertise and support they need to effectively manage digestive health and improve their overall quality of life."
"Knowing where to turn, in moments of need, is so often the defining moment in patients' journeys – especially for such a complex and under-resourced specialty like gastroenterology. We are excited to partner with Accolade to bring our proven GI care to their customer base," said Sam Holliday, Oshi Health's CEO. "By joining forces, we are increasing access to high-quality GI specialists, empowering more individuals to get the expert support they need to manage their digestive health and achieve lasting control."
Oshi Health is in-network with major insurance plans and its coverage continues to grow. Accolade and Oshi will provide joint customers with purpose-built integrations that address barriers to GI care while raising awareness of Oshi's integrated care model and team of GI clinical specialists.
About Accolade's Trusted Partner Ecosystem
Launched in 2019, Accolade's Trusted Partner Ecosystem accelerates the performance of digital health solutions to improve outcomes across valued categories for employers. Accolade's ecosystem currently consists of 19 partners across 12 categories.
Benefits teams can confidently select from thoroughly vetted solutions and enjoy streamlined contracting and implementation. Through qualified referrals, Accolade drives more engagement with partner solutions, leading to exponentially better health outcomes and better value. Learn more here.
About Accolade
Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade's employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinions, and best-in-class care navigation. These offerings are built on a platform engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over
About Oshi Health
Oshi Health is a redesigned digestive healthcare experience that transforms access to care, the patient experience, clinical outcomes, and healthcare economics. In a high-touch virtual care delivery model, Oshi Health diagnoses and provides integrated treatment for digestive conditions and empowers people to achieve lasting control of their symptoms. As the only national scale virtual GI center of excellence, Oshi Health works with innovative employers, health insurance partners, health systems, and community GI practices to scale access to multidisciplinary care, reduce healthcare costs, and improve the lives of millions of Americans with chronic gastrointestinal diseases. For more information, visit www.oshihealth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/accolade-welcomes-oshi-health-to-trusted-partner-ecosystem-302394552.html
SOURCE Accolade, Inc.
FAQ
What is the success rate of Oshi Health's GI treatment program with ACCD?
How many Americans are affected by GI diseases according to ACCD's partnership announcement?
What is the average waiting time for GI diagnosis that ACCD's partnership aims to reduce?
How will the Oshi Health partnership integrate with ACCD's existing services?
